lenalidomide has been researched along with Carcinoma, Adenoid Cystic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alese, OB; Bilen, MA; Carthon, BC; Chen, Z; El-Rayes, BF; Harris, WB; Harvey, RD; Hossain, MS; Khuri, FR; Lawson, DH; Lewis, C; Lonial, S; Owonikoko, TK; Ramalingam, SS; Shaib, W; Steuer, CE; Waller, EK; Wu, C; Zhang, C | 1 |
1 trial(s) available for lenalidomide and Carcinoma, Adenoid Cystic
Article | Year |
---|---|
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Cytokines; Everolimus; Female; Humans; Lenalidomide; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms | 2020 |